Amplyx brings in $67mm via Series C

15:40 EDT 7 Aug 2017 | Elsevier Business Intelligence

Antifungals developer Amplyx Pharmaceuticals Inc. raised $67mm in its Series C financing led by Sofinnova Venture Partners, w...

Original Article: Amplyx brings in $67mm via Series C


More From BioPortfolio on "Amplyx brings in $67mm via Series C"

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...